{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:33Z","timestamp":1787022093399,"version":"build-2736575974"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007941","name":"addis ababa university","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009053","name":"bill and melinda gates institute for population and reproductive health","doi-asserted-by":"publisher","award":["OPP1162384"],"award-info":[{"award-number":["OPP1162384"]}],"id":[{"id":"10.13039\/100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early diagnosis and treatment are one of the key strategies of tuberculosis control globally, and there are strong efforts in detecting and treating tuberculosis cases in Ethiopia. Smear microscopy examination has been a routine diagnostic test for pulmonary tuberculosis diagnosis in resource-constrained settings for decades. Recently, many countries, including Ethiopia, are scaling up the use of Gene Xpert without the evaluation of the cost and cost-effectiveness implications of this strategy. Therefore, this study evaluated the cost and cost-effectiveness of Gene Xpert (MTB\/RIF) and smear microscopy tests to diagnosis tuberculosis patients in Ethiopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared the costs and cost-effectiveness of tuberculosis diagnosis using smear microscopy and Gene Xpert among 1332 patients per intervention in the Arsi zone. We applied combinations of top-down and bottom-up costing approaches. The costs were estimated from the health providers\u2019 perspective within one year (2017\u20132018). We employed \u201ccases detected\u201d as an effectiveness measure, and the incremental cost-effectiveness ratio was calculated by dividing the changes in cost and change in effectiveness. All costs and incremental cost-effectiveness ratio were reported in 2018 US$.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The unit cost per test for Gene Xpert was $12.9 whereas it is $3.1 for AFB smear microscopy testing. The cost per TB case detected was $77.9 for Gene Xpert while it was $55.8 for the smear microscopy method. The cartridge kit cost accounted for 42% of the overall Gene Xpert\u2019s costs and the cost of the reagents and consumables accounted for 41.3% ($1.3) of the unit cost for the smear microscopy method. The ICER for the Gene Xpert strategy was $20.0 per tuberculosis case detected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Using Gene Xpert as a routine test instead of standard care (smear microscopy) can be potentially cost-effective. In the cost scenario analysis, the price of the cartridge, the number of tests performed per day, and the life span of the capital equipment were the drivers of the unit cost of the Gene Xpert method. Therefore, Gene Xpert can be a part of the routine TB diagnostic testing strategy in Ethiopia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0259056","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T13:24:39Z","timestamp":1635168279000},"page":"e0259056","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-3656","authenticated-orcid":true,"given":"Abdene Weya","family":"Kaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4872-8036","authenticated-orcid":true,"given":"Alemayehu","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"pone.0259056.ref001","author":"WHO","year":"2018","journal-title":"Global tuberculosis report"},{"issue":"3","key":"pone.0259056.ref002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1473-3099(17)30703-X","article-title":"The global burden of tuberculosis: results from the Global Burden of Disease Study 2015","volume":"18","author":"HH Kyu","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0259056.ref003","author":"FMOH","year":"2015"},{"key":"pone.0259056.ref004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2147\/CEOR.S92244","article-title":"Screening strategies for active tuberculosis: focus on cost-effectiveness","volume":"8","author":"CC Dobler","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"issue":"2","key":"pone.0259056.ref005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ccm.2005.02.012","article-title":"The diagnosis of tuberculosis","volume":"26","author":"D Brodie","year":"2005","journal-title":"Clin Chest Med"},{"key":"pone.0259056.ref006","article-title":"Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis.","author":"AK Detjen","year":"2015","journal-title":"Lancet Respiratory Medicine"},{"key":"pone.0259056.ref007","first-page":"3","article-title":"Xpert MTB\/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomized trial embedded in South African roll-out of Xpert MTB\/RIF.","author":"GJ Churchyard","year":"2015","journal-title":"Lancet Global Health"},{"issue":"1","key":"pone.0259056.ref008","doi-asserted-by":"crossref","DOI":"10.9745\/GHSP-D-12-00004","article-title":"GeneXpert for TB diagnosis: planned and purposeful implementation.","volume":"1","author":"AS Piatek","year":"2013","journal-title":"Global Health Science and Practice"},{"issue":"9","key":"pone.0259056.ref009","doi-asserted-by":"crossref","first-page":"e73717","DOI":"10.1371\/journal.pone.0073717","article-title":"The diagnostic performance of a single GeneXpert MTB\/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in Malaysia.","volume":"8","author":"HA Al-Darraji","year":"2013","journal-title":"PLoS One"},{"key":"pone.0259056.ref010","article-title":"Xpert MTB\/RIF assay for the diagnosis of TB","author":"WHO","year":"2016"},{"issue":"10","key":"pone.0259056.ref011","doi-asserted-by":"crossref","first-page":"e0205233","DOI":"10.1371\/journal.pone.0205233","article-title":"Cost-effectiveness of GeneXpert and LED-FM for diagnosis of pulmonary tuberculosis: A systematic review","volume":"13","author":"KD Sagili","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"pone.0259056.ref012","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.5588\/ijtld.11.0392","article-title":"Xpert\u00ae MTB\/RIF for national tuberculosis programmes in low-income countries: when, where and how?","volume":"15","author":"A Tr\u00e9bucq","year":"2011","journal-title":"International journal of tuberculosis and lung disease"},{"key":"pone.0259056.ref013","author":"WHO","year":"2013","journal-title":"Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children"},{"issue":"11","key":"pone.0259056.ref014","doi-asserted-by":"crossref","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","article-title":"Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis","volume":"8","author":"A Vassall","year":"2011","journal-title":"PLoS Med"},{"key":"pone.0259056.ref015","author":"Ethiopia FMoHo","year":"2017"},{"key":"pone.0259056.ref016","article-title":"National policy updates summary on six edition of National TB, TB\/HIV and Leprosy guidelines","author":"FMOH","year":"2016"},{"key":"pone.0259056.ref017","author":"FMOH","year":"2018","edition":"2"},{"key":"pone.0259056.ref018","article-title":"Ensuring an interrupted supply of quality assured, affordable tuberculosis medicines and diagnostic to the world","author":"partnership\/GDF ST","year":"2018"},{"key":"pone.0259056.ref019","author":"F Diagnostics","year":"2019","journal-title":"Negotiated Product Pricing 21"},{"issue":"3","key":"pone.0259056.ref020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5588\/ijtld.12.0392","article-title":"Point-of-care Xpert(R) MTB\/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.","volume":"17","author":"A Van Rie","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0259056.ref021","first-page":"17","article-title":"Is introducing rapid culture in the diagnostic algorithm of smear-negative tuberculosis cost-effective?","author":"Nadia Yakhelef","year":"2013"},{"key":"pone.0259056.ref022","unstructured":"Ethiopia: Macroeconomic and Social Indicators (2018\u20132019) [Internet]. 2020. Available from: https:\/\/nbebank.com\/wp-content\/uploads\/pdf\/annualbulletin\/report-2018-2019.pdf."},{"issue":"291","key":"pone.0259056.ref023","article-title":"Comparison of direct versus concentrated smear microscopy in the detection of pulmonary tuberculosis","volume":"6","author":"MKM Uddin","year":"2013","journal-title":"BMC Research Notes"},{"issue":"6","key":"pone.0259056.ref024","doi-asserted-by":"crossref","first-page":"e0157554","DOI":"10.1371\/journal.pone.0157554","article-title":"Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis.","volume":"11","author":"S Jha","year":"2016","journal-title":"PLoS One"},{"key":"pone.0259056.ref025","article-title":"Cost-effectiveness of WHO-Recommended Algorithms for TB Case Finding at Ethiopian HIV Clinics","author":"MW Adelman","year":"2017","journal-title":"Infectious disease society of America"},{"issue":"8","key":"pone.0259056.ref026","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/QAD.0b013e3283522d47","article-title":"The cost-effectiveness of routine tuberculosis screening with Xpert MTB\/RIF prior to initiation of antiretroviral therapy: a model-based analysis","volume":"26","author":"JR Andrews","year":"2012","journal-title":"AIDS"},{"issue":"10","key":"pone.0259056.ref027","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.5588\/ijtld.13.0095","article-title":"Cost-effectiveness of Xpert\u00ae MTB\/RIF for diagnosing pulmonary tuberculosis in the United States","volume":"17","author":"HW Choi","year":"2013","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"1","key":"pone.0259056.ref028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAI.0000000000000712","article-title":"Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis.","volume":"70","author":"AA Zwerling","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"pone.0259056.ref029","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.5588\/ijtld.16.0200","article-title":"Higher cost of implementing Xpert((R)) MTB\/RIF in Ugandan peripheral settings: implications for cost-effectiveness","volume":"20","author":"E Hsiang","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"pone.0259056.ref030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12913-016-1804-9","article-title":"Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB\/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.","volume":"16","author":"S Walusimbi","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"pone.0259056.ref031","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1590\/s1806-37562015000004524","article-title":"Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System","volume":"41","author":"M Pinto","year":"2015","journal-title":"Journal of Brasil Pneumol"},{"issue":"4","key":"pone.0259056.ref032","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5588\/ijtld.16.0496","article-title":"Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.","volume":"21","author":"S Rupert","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"issue":"352","key":"pone.0259056.ref033","article-title":"Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for the detection of tuberculosis and drug-resistant tuberculosis in South Africa","volume":"13","author":"Maunank Shah","year":"2013","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"pone.0259056.ref034","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1183\/09031936.00147912","article-title":"Xpert MTB\/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis","volume":"42","author":"A Pantoja","year":"2013","journal-title":"Eur Respir J"},{"issue":"8","key":"pone.0259056.ref035","doi-asserted-by":"crossref","first-page":"e0183237","DOI":"10.1371\/journal.pone.0183237","article-title":"Peripheral clinic versus centralized laboratory-based Xpert MTB\/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana","volume":"12","author":"T Agizew","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"pone.0259056.ref036","doi-asserted-by":"crossref","first-page":"e0225205","DOI":"10.1371\/journal.pone.0225205","article-title":"Monitoring quality indicators for the Xpert MTB\/RIF molecular assay in Ethiopia","volume":"14","author":"A Kebede","year":"2019","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T13:25:14Z","timestamp":1635168314000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259056"}},"subtitle":[],"editor":[{"given":"Frederick","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0259056","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]}}}